How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out how well a long-acting beta agonist like salmeterol
works in people with different forms of the same gene. Our hypothesis is that asthmatics with
the Arg/Arg genotype will have loss of bronchoprotection against exercise-induced asthma with
regular salmeterol treatment, as compared to asthmatics with the Gly/Gly genotype.